SPECT used to investigate therapy to slow Alzheimer's progression

01/1/2009 | Ridgefield Press (Conn.), The

The ICARA study is using SPECT scans to investigate the efficacy of an intravenous medication called Bapineuzumab in slowing down the progression of late-stage Alzheimer's disease. The treatment also has antibody proteins that help to clear amyloid within the plaque in the brain.

View Full Article in:

Ridgefield Press (Conn.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY